Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2082524 | Drug Discovery Today: Technologies | 2013 | 12 Pages |
Abstract
Allosteric modulators of adenosine receptors represent an alternative to direct-acting adenosine agonists and nucleoside uptake blockers, preferably those can selectively modulate the response to adenosine in only those organs or localized areas of a given organ in which production of adenosine is increased. Allosteric enhancers at the adenosine A1 receptor have received attention as anti-arrhythmic cardiac agents, and, more recently, as anti-lipolytic agents. In addition, this class of compounds has therapeutic potential as analgesics and neuroprotective agents.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
MarĂa Kimatrai-Salvador, Pier Giovanni Baraldi, Romeo Romagnoli,